Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has been given an average recommendation of “Moderate Buy” by the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company.

Several brokerages have issued reports on STVN. BNP Paribas started coverage on shares of Stevanato Group in a research report on Monday. They set an “outperform” rating for the company. Stephens reaffirmed an “overweight” rating and set a $38.00 target price on shares of Stevanato Group in a report on Monday, March 25th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $30.00 target price on shares of Stevanato Group in a report on Monday.

Stevanato Group Price Performance

Shares of STVN stock opened at €27.52 ($29.28) on Friday. The firm has a 50 day moving average price of €30.08 and a two-hundred day moving average price of €29.45. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50. Stevanato Group has a 12-month low of €23.00 ($24.47) and a 12-month high of €36.30 ($38.62).

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.19 ($0.20) by (€0.01) (($0.01)). The company had revenue of €320.60 million for the quarter, compared to analyst estimates of €326.85 million. Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The company’s revenue was up 9.8% on a year-over-year basis. During the same quarter last year, the business earned $0.19 earnings per share. Research analysts predict that Stevanato Group will post 0.67 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in STVN. Trust Point Inc. bought a new position in Stevanato Group in the fourth quarter valued at approximately $252,000. Yorktown Management & Research Co Inc bought a new position in Stevanato Group in the fourth quarter valued at approximately $254,000. Riverbridge Partners LLC increased its stake in Stevanato Group by 78.1% in the fourth quarter. Riverbridge Partners LLC now owns 1,274,805 shares of the company’s stock valued at $34,789,000 after acquiring an additional 559,070 shares during the last quarter. Raymond James & Associates increased its stake in Stevanato Group by 0.9% in the third quarter. Raymond James & Associates now owns 197,316 shares of the company’s stock valued at $5,864,000 after acquiring an additional 1,806 shares during the last quarter. Finally, Natixis Advisors L.P. increased its stake in Stevanato Group by 2.6% in the third quarter. Natixis Advisors L.P. now owns 23,409 shares of the company’s stock valued at $696,000 after acquiring an additional 590 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.